{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T17:53:25Z","timestamp":1791309205308,"version":"4.3.1"},"reference-count":5,"publisher":"BMJ","content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["Eur J Hosp Pharm"],"DOI":"10.1136\/ejhpharm-2026-005390","type":"journal-article","created":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T17:20:33Z","timestamp":1791307233000},"page":"ejhpharm-2026-005390","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":0,"title":["When excipients matter: cyclodextrins, renal impairment and intravenous drug therapy"],"prefix":"10.1136","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8672-9075","authenticated-orcid":false,"given":"Silvia","family":"V\u00e1zquez-G\u00f3mez","sequence":"first","affiliation":[{"name":"Pharmacy, Complejo Hospitalario Universitario de Pontevedra, Pontevedra, Galicia, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-4020-4892","authenticated-orcid":false,"given":"Sandra","family":"Ca\u00ed\u00f1a L\u00f3pez","sequence":"additional","affiliation":[{"name":"Pharmacy, Complejo Hospitalario Universitario de Pontevedra, Pontevedra, Galicia, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2026,10,6]]},"reference":[{"key":"2026100610202464000_ejhpharm-2026-005390v1.1","doi-asserted-by":"crossref","first-page":"443","DOI":"10.4155\/tde-2023-0026","article-title":"A comprehensive review on pharmaceutical excipients","volume":"14","author":"Pockle","year":"2023","journal-title":"Ther Deliv"},{"key":"2026100610202464000_ejhpharm-2026-005390v1.2","first-page":"31","article-title":"Aplicaci\u00f3n de las ciclodextrinas como excipientes en productos farmac\u00e9uticos: \u00bfpor qu\u00e9 no en formulaci\u00f3n magistral? [in Spanish]","volume":"46","author":"Ramos-Mart\u00ednez","year":"2022","journal-title":"Farm Hosp"},{"key":"2026100610202464000_ejhpharm-2026-005390v1.3","unstructured":"European Medicines Agency . Cyclodextrins used as excipients. 2017. Available: https:\/\/www.ema.europa.eu\/en\/documents\/scientific-guideline\/questions-and-answers-cyclodextrins-used-excipients-medicinal-products-human-use_en.pdf [Accessed 7 Sep 2026]."},{"key":"2026100610202464000_ejhpharm-2026-005390v1.4","unstructured":"European Medicines Agency . Vfend: EPAR \u2013 product information. 2026. Available: https:\/\/www.ema.europa.eu\/en\/documents\/product-information\/vfend-epar-product-information_en.pdf"},{"key":"2026100610202464000_ejhpharm-2026-005390v1.5","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijantimicag.2015.05.023"}],"container-title":["European Journal of Hospital Pharmacy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/ejhpharm-2026-005390","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T17:20:34Z","timestamp":1791307234000},"score":1,"resource":{"primary":{"URL":"https:\/\/ejhp.bmj.com\/lookup\/doi\/10.1136\/ejhpharm-2026-005390"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10,6]]},"references-count":5,"alternative-id":["10.1136\/ejhpharm-2026-005390"],"URL":"https:\/\/doi.org\/10.1136\/ejhpharm-2026-005390","relation":{},"ISSN":["2047-9956","2047-9964"],"issn-type":[{"value":"2047-9956","type":"print"},{"value":"2047-9964","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,10,6]]}}}